Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 7945848, 8 pages
http://dx.doi.org/10.1155/2016/7945848
Research Article

Targeting Endothelial Adhesion Molecule Transcription for Treatment of Inflammatory Disease: A Proof-of-Concept Study

Eye & Vision Health, Flinders University School of Medicine, Flinders Medical Centre, Flinders Drive, Bedford Park, SA 5042, Australia

Received 4 December 2015; Accepted 18 April 2016

Academic Editor: Ronald Gladue

Copyright © 2016 Liam M. Ashander et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Nourshargh and R. Alon, “Leukocyte migration into inflamed tissues,” Immunity, vol. 41, no. 5, pp. 694–707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. J. Nolan, M. Ginsberg, E. Israely et al., “Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration,” Developmental Cell, vol. 26, no. 2, pp. 204–219, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Bullard, “Adhesion molecules in inflammatory diseases: insights from knockout mice,” Immunologic Research, vol. 26, no. 1–3, pp. 27–33, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. D. Luster, R. Alon, and U. H. von Andrian, “Immune cell migration in inflammation: present and future therapeutic targets,” Nature Immunology, vol. 6, no. 12, pp. 1182–1190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. S. Kupper and R. C. Fuhlbrigge, “Immune surveillance in the skin: mechanisms and clinical consequences,” Nature Reviews Immunology, vol. 4, no. 3, pp. 211–222, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Ousman and P. Kubes, “Immune surveillance in the central nervous system,” Nature Neuroscience, vol. 15, no. 8, pp. 1096–1101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Derfuss, J. Kuhle, R. Lindberg, and L. Kappos, “Natalizumab therapy for multiple sclerosis,” Seminars in Neurology, vol. 33, no. 1, pp. 26–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. H. F. Langer and T. Chavakis, “Leukocyte—endothelial interactions in inflammation,” Journal of Cellular and Molecular Medicine, vol. 13, no. 7, pp. 1211–1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Pate, V. Damarla, D. S. Chi, S. Negi, and G. Krishnaswamy, “Endothelial cell biology. Role in the inflammatory response,” Advances in Clinical Chemistry, vol. 52, pp. 109–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. D. de Smet, S. R. J. Taylor, B. Bodaghi et al., “Understanding uveitis: the impact of research on visual outcomes,” Progress in Retinal and Eye Research, vol. 30, no. 6, pp. 452–470, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Bharadwaj, L. P. Schewitz-Bowers, L. Wei, R. W. J. Lee, and J. R. Smith, “Intercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endothelium,” Investigative Ophthalmology and Visual Science, vol. 54, no. 10, pp. 6917–6925, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Q. Zhang, Y. Jiang, J. J. Toutounchian, C. Soderland, C. R. Yates, and J. J. Steinle, “Insulin-like growth factor binding protein-3 inhibits monocyte adhesion to retinal endothelial cells in high glucose conditions,” Molecular Vision, vol. 19, pp. 796–803, 2013. View at Google Scholar · View at Scopus
  13. S. Sugita, Y. Kawazoe, A. Imai, Y. Yamada, S. Horie, and M. Mochizuki, “Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease,” Arthritis Research & Therapy, vol. 14, no. 3, article R99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Nagata, K. Maruyama, K. Uno et al., “Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis,” Investigative Ophthalmology and Visual Science, vol. 53, no. 7, pp. 3827–3833, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. J. Kuiper, A. Rothova, P. A. Schellekens, A. Ossewaarde-van Norel, A. C. Bloem, and T. Mutis, “Detection of choroid- and retina-antigen reactive CD8(+) and CD4(+) T lymphocytes in the vitreous fluid of patients with birdshot chorioretinopathy,” Human Immunology, vol. 75, no. 6, pp. 570–577, 2014. View at Google Scholar
  16. M. Mesquida, B. Molins, V. Llorenç et al., “Proinflammatory cytokines and C-reactive protein in uveitis associated with Behçet's disease,” Mediators of Inflammation, vol. 2014, Article ID 396204, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. B. Suhler, J. R. Smith, T. R. Giles et al., “Infliximab therapy for refractory uveitis: 2-year results of a prospective trial,” Archives of Ophthalmology, vol. 127, no. 6, pp. 819–822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. B. Suhler, J. R. Smith, M. S. Wertheim et al., “A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes,” Archives of Ophthalmology, vol. 123, no. 7, pp. 903–912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. N. A. Rao, M. T. McCalman, P. Moulos et al., “Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes,” Genome Research, vol. 21, no. 9, pp. 1404–1416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Lu, K. Fukuda, Y. Nakamura, K. Kimura, N. Kumagai, and T. Nishida, “Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts,” Investigative Ophthalmology & Visual Science, vol. 46, no. 7, pp. 2346–2352, 2005. View at Publisher · View at Google Scholar
  21. A. Sandelin, W. Alkema, P. Engström, W. W. Wasserman, and B. Lenhard, “JASPAR: an open-access database for eukaryotic transcription factor binding profiles,” Nucleic Acids Research, vol. 32, pp. D91–D94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Bharadwaj, B. Appukuttan, P. A. Wilmarth et al., “Role of the retinal vascular endothelial cell in ocular disease,” Progress in Retinal and Eye Research, vol. 32, no. 1, pp. 102–180, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. C. L. Kalbert, G. W. Demers, and D. A. Galloway, “The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells,” Journal of Virology, vol. 65, no. 1, pp. 473–478, 1991. View at Google Scholar · View at Scopus
  24. W. Hartwig, J. Werner, A. L. Warshaw et al., “Membrane-bound ICAM-1 is upregulated by trypsin and contributes to leukocyte migration in acute pancreatitis,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 287, no. 6, pp. G1194–G1199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. van de Stolpe and P. T. van der Saag, “Intercellular adhesion molecule-1,” Journal of Molecular Medicine, vol. 74, no. 1, pp. 13–33, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. C.-C. Chen, “Signal transduction pathways of inflammatory gene expressions and therapeutic implications,” Current Pharmaceutical Design, vol. 12, no. 27, pp. 3497–3508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Yalcin, N. Atakan, and N. Alli, “The functional role of nuclear factor kappa-κB1 −94 ins/del ATTG promotor gene polymorphism in Behçet's disease: an exploratory study,” Clinical and Experimental Dermatology, vol. 33, no. 5, pp. 629–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Yenmis, T. Oner, C. Cam et al., “Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of behçet's disease,” Scandinavian Journal of Immunology, vol. 81, no. 1, pp. 81–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Yan and P. J. Higgins, “Drugging the undruggable: transcription therapy for cancer,” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, vol. 1835, no. 1, pp. 76–85, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. Yeh, P. A. Toniolo, and D. A. Frank, “Targeting transcription factors: promising new strategies for cancer therapy,” Current Opinion in Oncology, vol. 25, no. 6, pp. 652–658, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. J. N. F. Scott, A. P. Kupinski, and J. Boyes, “Targeted genome regulation and modification using transcription activator-like effectors,” FEBS Journal, vol. 281, no. 20, pp. 4583–4597, 2014. View at Publisher · View at Google Scholar · View at Scopus